Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
American Journal of Medical Genetics. Part A|December 10, 2021
Sleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohortDejan B Budimirovic, Dragana D Protic, Carol M Delahunty, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|August 30, 2016
Vagally-mediated heart rate variability and indices of well-being: Results of a nationally representative studyRichard P Sloan, Emilie Schwarz, Paula S McKinley, et al.
Frontiers in Physiology|September 11, 2023
Cardiovascular variability, sociodemographics, and biomarkers of disease: the MIDUS studyTara Gruenewald, Teresa E Seeman, Tse-Hwei Choo, et al.
Frontiers in Psychiatry|June 21, 2021
Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot StudyZhengchao Dong, Michael F Grunebaum, Martin J Lan, et al.
Journal of Psychiatric Research|August 16, 2019
Ketamine metabolite pilot study in a suicidal depression trialMichael F Grunebaum, Hanga C Galfalvy, Tse-Hwei Choo, et al.
Drug and Alcohol Dependence|December 22, 2020
An alternative analysis of illicit opioid use during treatment in a randomized trial of extended-release naltrexone versus buprenorphine-naloxone: A per-protocol and completers analysisMary M Mitchell, Robert P Schwartz, Tse-Hwei Choo, et al.
Journal of Addiction Medicine|October 3, 2023
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use DisorderMatisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.
Drug and Alcohol Dependence|May 23, 2022
Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexoneJudith I Tsui, Aimee N C Campbell, Martina Pavlicova, et al.
Substance Use & Misuse|April 3, 2026
Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT TrialKenzie Potter, Miranda Greiner, Matisyahu Shulman, et al.
Journal of Affective Disorders|August 1, 2020
Heterogeneity in Fear Processing across and within Anxiety, Eating, and Compulsive DisordersAbby J Fyer, Franklin R Schneier, Helen Blair Simpson, et al.
Pageof 8